The risk of CRC in AXIN2 pathogenic variant carriers is not precisely estimated; however, these patients should undergo a surveillance protocol, including a high-quality colonoscopy starting at age 25–30 years, to be repeated every 2–3 years if negative. Here, AXIN2 is linked to colorectal carcinoma.